<DOC>
	<DOC>NCT00892944</DOC>
	<brief_summary>The purpose of this study is to determine if AZD2516 binds to mGluR5 receptors in the brain. This will then help to make accurate predictions of efficacy and dosing in the future development programme.</brief_summary>
	<brief_title>An Open Label Positron Emission Tomography (PET) Study to Determine Central mGluR5 Receptor Occupancy of AZD2516</brief_title>
	<detailed_description />
	<criteria>Normal MRI scan Healthy male or nonfertile females Body Mass Index (BMI) of ≥19 to ≤28 kg/m2 and weight of ≥50 to ≤100 kg History of disease or condition that may interfere with the objectives of the study History of previous or ongoing psychiatric disease/condition Concomitant medication</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>October 2009</verification_date>
	<keyword>Positron Emission Tomography</keyword>
	<keyword>Phase 1</keyword>
	<keyword>Healthy volunteers</keyword>
	<keyword>AZD2516</keyword>
</DOC>